ERA4TB – Closing the gap between early bacterial activity and clinical cure

Santiago Ramon Garcia,
ARAID Investigator, ARAID Foundation/University of Zaragoza, Dept. Microbiology, Zaragoza, Spain

Oscar Della Pasqua
Research Associate, National Research Council (CNR) Rome. Italy

Novel in vitro tools to inform pre-clinical and clinical progression of TB combination therapy
Santiago Ramon Garcia
ARAID Investigator, ARAID Foundation/ University of Zaragoza, Dept. Microbiology, Zaragoza, Spain

Treatment relapse: interaction between the immune system and anti-tubercular drugs
Oscar Della Pasqua
Research Associate, National Research Council (CNR), Rome, Italy

Selection of companion drugs and dose rationale for combination therapy
Dr Silvia Grandoni
Post-doctoral Fellow, National Research Council, Rome, Italy

Modelling of the immune response and prediction of treatment relapse
Enrico Mastrostefano
Research Fellow, National Research Council (CNR), Rome. Italy

Understanding drug distribution in lung tissue, lesion and granulomas
Aris Dokoumetzidis
Associate Professor, "Athena" Research and Innovation Center, Athens, Greece